Krsnaa Diagnostics Limited
NSE: KRSNAA · Unclassified
Ask the data
Instant answers about Krsnaa Diagnostics Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Revenue | 455.4 | 487.1 | 619.6 | 717.2 | 772.8 |
| EBITDA | 131.5 | 122.3 | 144.2 | 190.1 | 211.9 |
| Operating margin | 28.9% | 25.1% | 23.3% | 26.5% | 27.4% |
| Interest | 18.5 | 7.7 | 16.5 | 24.6 | 34.4 |
| Depreciation | 41.4 | 53.8 | 74.5 | 88.3 | 90.5 |
| Profit before tax | 86.5 | 80.2 | 70.0 | 102.7 | 130.4 |
| Tax | 18.1 | 18.1 | 13.2 | 25.1 | 28.9 |
| Net profit | 68.4 | 62.1 | 56.8 | 77.6 | 101.4 |
| EPS ₹ | 22.89 | 19.78 | 17.90 | 24.04 | 31.30 |
| Operating cash flow | 128.4 | 76.3 | 24.3 | 87.3 | 143.1 |
| Capex | 132.2 | 141.4 | 193.9 | 126.6 | 219.3 |
| Dividend paid | 0.0 | 7.8 | 8.6 | 8.1 | 8.9 |
| Total assets | — | 909.9 | 1,171.9 | 1,281.6 | 1,823.7 |
| Equity | — | 738.7 | 809.8 | 882.8 | 980.4 |
Quarterly performance
last 21 quarters · ₹ crore| SEP '21 | DEC '21 | MAR '22 | JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 108.3 | 106.5 | 108.2 | 112.9 | 122.9 | 118.1 | 133.2 | 139.6 | 155.4 | 158.3 | 166.3 | 170.2 | 186.3 | 174.5 | 186.1 | 193.0 | 206.0 | 181.2 | 192.6 | 235.5 | 271.0 |
| Operating profit | 31.9 | 30.0 | 28.0 | 27.8 | 30.6 | 29.4 | 34.5 | 31.4 | 31.8 | 37.4 | 43.7 | 42.7 | 49.4 | 45.1 | 53.0 | 51.4 | 59.2 | 46.4 | 54.9 | 58.0 | 71.1 |
| Operating margin | 29.5% | 28.2% | 25.9% | 24.6% | 24.9% | 24.9% | 25.9% | 22.5% | 20.5% | 23.6% | 26.3% | 25.1% | 26.5% | 25.8% | 28.5% | 26.6% | 28.7% | 25.6% | 28.5% | 24.6% | 26.2% |
| Other income | 3.2 | 4.3 | 4.1 | 4.6 | 4.3 | 4.5 | 5.9 | 4.2 | 4.2 | 4.1 | 4.3 | 7.3 | 4.6 | 9.2 | 4.4 | 4.0 | 4.2 | 3.8 | 31.5 | 7.2 | 6.2 |
| Interest | 8.2 | 2.4 | 1.8 | 1.4 | 1.8 | 2.3 | 2.2 | 2.0 | 3.1 | 4.1 | 7.3 | 5.3 | 6.4 | 6.1 | 6.8 | 6.3 | 8.2 | 7.8 | 12.1 | 14.8 | 15.4 |
| Depreciation | 10.3 | 10.6 | 10.4 | 12.4 | 12.9 | 13.9 | 14.6 | 15.7 | 19.5 | 21.2 | 18.1 | 21.5 | 22.2 | 22.7 | 21.9 | 21.6 | 23.6 | 22.7 | 22.6 | 27.9 | 29.1 |
| Profit before tax | 16.6 | 21.4 | 19.9 | 18.7 | 20.2 | 17.8 | 23.6 | 17.9 | 13.4 | 16.1 | 22.6 | 23.2 | 25.4 | 25.5 | 28.6 | 27.4 | 31.6 | 19.8 | 51.7 | 22.4 | 32.8 |
| Tax | 4.1 | 5.0 | 1.9 | 4.5 | 4.8 | 4.1 | 4.7 | 3.2 | 2.9 | 3.1 | 3.9 | 5.3 | 5.8 | 6.1 | 7.9 | 6.9 | 7.6 | 4.4 | 10.0 | 5.9 | 8.2 |
| Net profit | 12.5 | 16.3 | 17.9 | 14.2 | 15.3 | 13.6 | 18.9 | 14.6 | 10.5 | 13.0 | 18.7 | 17.9 | 19.6 | 19.4 | 20.7 | 20.5 | 23.9 | 0.0 | 41.7 | 16.6 | 24.6 |
| EPS ₹ | 4.51 | 5.67 | 5.40 | 4.53 | 5.73 | 4.35 | 6.03 | 4.66 | 3.35 | 4.09 | 5.80 | 5.55 | 6.07 | 6.01 | 6.40 | 6.35 | 7.38 | 4.72 | 12.86 | 5.10 | 7.64 |
| Revenue YoY | — | — | — | — | 13.6% | 10.9% | 23.1% | 23.7% | 26.4% | 34.1% | 24.8% | 22.0% | 19.9% | 10.2% | 11.9% | 13.4% | 10.5% | 3.8% | 3.5% | 22.0% | 31.5% |
| Profit YoY | — | — | — | — | 22.4% | -16.5% | 5.5% | 3.0% | -31.6% | -4.9% | -1.0% | 22.4% | 86.7% | 49.7% | 10.4% | 14.5% | 22.2% | -100.0% | 101.7% | -19.3% | 2.7% |
Returns & margins
trailing-twelve-month, per quarter| JUN '22 | SEP '22 | DEC '22 | MAR '23 | JUN '23 | SEP '23 | DEC '23 | MAR '24 | JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | 9.0% | 8.7% | 8.4% | 8.5% | 7.6% | 7.6% | 7.0% | 7.4% | 8.2% | 9.0% | 8.8% | 9.1% | 9.2% | 7.1% | 8.8% | 8.4% | 8.0% |
| ROCE | — | 11.4% | 10.9% | 11.4% | 11.4% | 9.5% | 9.5% | 8.9% | 9.8% | 10.5% | 11.5% | 11.7% | 12.2% | 11.6% | 11.3% | 10.9% | 11.1% | 10.8% |
| Net margin | 14.0% | 14.2% | 13.2% | 12.8% | 12.2% | 10.6% | 9.7% | 9.2% | 9.2% | 10.2% | 10.8% | 10.8% | 10.8% | 11.1% | 8.5% | 11.2% | 10.1% | 9.4% |
| EBITDA margin | 27.0% | 25.8% | 25.1% | 25.1% | 24.5% | 23.3% | 23.0% | 23.3% | 23.9% | 25.4% | 25.9% | 26.5% | 26.9% | 27.5% | 27.4% | 27.4% | 26.8% | 26.2% |
| Debt / equity | — | 0.09 | 0.09 | 0.04 | 0.04 | 0.14 | 0.14 | 0.20 | 0.20 | 0.26 | 0.26 | 0.23 | 0.23 | 0.31 | 0.31 | 0.55 | 0.55 | 0.57 |
| Interest coverage | 6.56 | 11.88 | 11.54 | 11.42 | 10.60 | 8.63 | 7.23 | 5.25 | 4.80 | 4.77 | 4.84 | 5.17 | 5.17 | 5.12 | 4.69 | 4.80 | 3.93 | 3.53 |
| Asset turnover | — | 0.49 | 0.50 | 0.54 | 0.56 | 0.51 | 0.54 | 0.53 | 0.55 | 0.53 | 0.54 | 0.56 | 0.58 | 0.50 | 0.51 | 0.42 | 0.45 | 0.43 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '22 | MAR '23 | SEP '23 | MAR '24 | SEP '24 | MAR '25 | SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Share capital | 15.7 | 15.7 | 15.7 | 16.1 | 16.1 | 16.1 | 16.2 | 16.2 | 16.2 |
| Other equity / reserves | 690.4 | 723.0 | 739.5 | 793.7 | 824.6 | 866.6 | 906.7 | 964.2 | 1,022.4 |
| Total equity | 706.1 | 738.7 | 755.2 | 809.8 | 840.8 | 882.8 | 923.0 | 980.4 | 1,038.6 |
| Borrowings | 62.6 | 32.5 | 109.2 | 159.8 | 216.1 | 203.5 | 285.7 | 534.3 | 596.4 |
| Current liabilities | 176.4 | 99.2 | 240.7 | 281.5 | 381.1 | 305.4 | 407.5 | 275.2 | 482.2 |
| Non-current liabilities | 42.2 | 72.0 | 81.6 | 80.6 | 72.7 | 93.4 | 176.3 | 568.1 | 542.7 |
| Total assets | 924.7 | 909.9 | 1,077.5 | 1,171.9 | 1,294.5 | 1,281.6 | 1,506.7 | 1,823.7 | 2,063.6 |
| Property, plant & equipment | 390.4 | 467.9 | 556.2 | 644.7 | 686.3 | 667.4 | 680.0 | 651.6 | 848.8 |
| Capital work-in-progress | 44.1 | 25.5 | 27.7 | 9.8 | 3.5 | 3.0 | 30.2 | 208.1 | 5.2 |
| Investments | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 31.5 | 31.6 | 57.4 | 57.4 |
| Inventories | 17.3 | 25.1 | 36.4 | 35.8 | 30.7 | 29.5 | 31.5 | 26.7 | 33.3 |
| Receivables | 114.2 | 73.1 | 158.7 | 176.3 | 243.5 | 277.8 | 358.3 | 295.5 | 474.6 |
| Cash & equivalents | 24.4 | 22.7 | 30.3 | 2.4 | 11.3 | 3.9 | 10.6 | 30.2 | 77.4 |
Cash flow
annual · ₹ crore · line = free cash flow| FY22 | FY23 | FY24 | FY25 | FY26 | |
|---|---|---|---|---|---|
| Cash from operations | 128.4 | 76.3 | 24.3 | 87.3 | 143.1 |
| Cash from investing | -240.6 | -108.9 | -128.9 | -99.6 | -396.0 |
| Cash from financing | 176.0 | -33.1 | 84.2 | 13.8 | 279.3 |
| Capex | 132.2 | 141.4 | 193.9 | 126.6 | 219.3 |
| Free cash flow | -3.8 | -65.1 | -169.5 | -39.3 | -76.2 |
| Dividends paid | 0.0 | 7.8 | 8.6 | 8.1 | 8.9 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Krsnaa Diagnostics Limited | 1,541 | 475.00 | 18.6 | 1.48 | 8.0% |
StoxGud checklist: Bearish setup · 3/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Krsnaa Diagnostics Limited?
Krsnaa Diagnostics Limited (KRSNAA) closed at ₹475.00 on NSE on 06 Nov 2026.
What is the market cap of Krsnaa Diagnostics Limited?
₹1,541 crore at the latest close.
What is the P/E ratio of Krsnaa Diagnostics Limited?
18.6, on trailing-twelve-month earnings from its filings.
How fast is Krsnaa Diagnostics Limited growing?
Krsnaa Diagnostics Limited: revenue has compounded at 16.6% a year over three years; net profit at 17.8% a year. Latest-quarter revenue is up 31.5% year on year, profit up 2.7%.
How profitable is Krsnaa Diagnostics Limited?
On a trailing-twelve-month basis return on equity is 8.0%, return on capital employed 10.8%, operating margin 26.2%, net margin 9.4%.
How much debt does Krsnaa Diagnostics Limited have?
Krsnaa Diagnostics Limited is moderately geared: debt to equity is 0.57 with borrowings of ₹596 cr against cash of ₹77 cr (balance sheet of 2026-09-30). Operating profit covers interest 3.5 times.
Financials parsed from Krsnaa Diagnostics Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '21, annual from FY22, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.